- Latest available (Revised)
- Point in Time (03/09/2008)
- Original (As adopted by EU)
Council Directive 92/35/EEC of 29 April 1992 laying down control rules and measures to combat African horse sickness
When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.
Legislation.gov.uk publishes the UK version. EUR-Lex publishes the EU version. The EU Exit Web Archive holds a snapshot of EUR-Lex’s version from IP completion day (31 December 2020 11.00 p.m.).
Version Superseded: 01/01/2019
EU Directives are published on this site to aid cross referencing from UK legislation. Since IP completion day (31 December 2020 11.00 p.m.) no amendments have been applied to this version.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Textual Amendments
F1 Deleted by Council Directive 2008/73/EC of 15 July 2008 simplifying procedures of listing and publishing information in the veterinary and zootechnical fields and amending Directives 64/432/EEC, 77/504/EEC, 88/407/EEC, 88/661/EEC, 89/361/EEC, 89/556/EEC, 90/426/EEC, 90/427/EEC, 90/428/EEC, 90/429/EEC, 90/539/EEC, 91/68/EEC, 91/496/EEC, 92/35/EEC, 92/65/EEC, 92/66/EEC, 92/119/EEC, 94/28/EC, 2000/75/EC, Decision 2000/258/EC and Directives 2001/89/EC, 2002/60/EC and 2005/94/EC (Text with EEA relevance).
The national laboratories for African horse sickness are responsible for coordinating the standards and diagnostic methods laid down in each diagnostic laboratory of the Member State, for the use of reagents and for the testing of vaccines. To this end, they:
may provide diagnostic reagents to diagnostic laboratories requesting them;
will control the quality of all diagnostic reagents used in that Member State;
will arrange comparative tests periodically;
will hold isolates of African horse sickness virus from cases confirmed in that Member State;
will ensure the confirmation of positive results obtained in regional diagnostic laboratories.
Textual Amendments
F2 Substituted by Commission Decision of 7 November 2007 amending Council Directives 64/432/EEC, 90/539/EEC, 92/35/EEC, 92/119/EEC, 93/53/EEC, 95/70/EC, 2000/75/EC, 2001/89/EC, 2002/60/EC, and Decisions 2001/618/EC and 2004/233/EC as regards lists of national reference laboratories and State institutes (notified under document number C(2007) 5311) (Text with EEA relevance) (2007/729/EC).
Laboratorio Central de Sanidad Animal de Algete
Carretera de Algete, km 8
E-28110 Algete (Madrid)
Tel. (34) 916 29 03 00
Fax (34) 916 29 05 98
Correo electrónico: lcv@mapya.es]
The Community reference laboratory has the following functions and duties:
to coordinate, in consultation with the Commission, the methods employed in the Member States for diagnosing African horse sickness, specifically by:
typing, storing and supplying strains of African horse sickness virus for serological tests and the preparation of antiserum;
supplying standard sera and other reference reagents to the national reference laboratories in order to standardize the tests and reagents used in each Member State;
building up and maintaining a collection of African horse sickness virus strains and isolates;
organizing periodical comparative tests of diagnostic procedures at Community level;
collecting and collating data and information on the methods of diagnosis used and the results of tests carried out in the Community;
characterizing isolates of African horse sickness by the most up-to-date methods available to allow greater understanding of the epizootiology of African horse sickness;
monitoring developments in African horse sickness surveillance, epizootiology and prevention throughout the world;
to assist actively in the diagnosis of African horse sickness outbreaks in Member States by receiving virus isolates for confirmatory diagnosis, characterization and epizootiologial studies;
to facilitate the training or retraining of experts in laboratory diagnosis with a view to the harmonization of techniques throughout the Community;
to carry out a mutual and reciprocal exchange of information with the world laboratory for African horse sickness designated by the International Office of Epizootics (IOE), in particular with regard to developments in the world situation concerning African horse sickness.
Contingency plans shall meet at least the following criteria:
the establishment of a crisis centre on a national level, which shall coordinate all control measures in the Member State concerned;
a list shall be provided of local disease control centres with adequate facilities to coordinate the disease control measures at a local level;
detailed information shall be given about the staff involved in control measures, their skills and their responsibilities;
each local disease control centre must be able to contact rapidly persons/organizations which are directly or indirectly involved in an outbreak;
equipment and materials shall be available to carry out the disease control measures properly;
detailed instructions shall be provided on action to be taken, including means of disposal of carcases, on suspicion and confirmation of infection or contamination;
training programmes shall be established to maintain and develop skills in field and administrative procedures;
diagnostic laboratories must have facilities for post-mortem examination, the necessary capacity for serology, histology, etc., and must maintain the skills for rapid diagnosis (to that end arrangements should be made for rapid transportation of samples);
details shall be provided of the quantity of African horse sickness vaccine estimated to be required in the event of a reinstatement of emergency vaccination;
provisions shall be made to ensure the legal powers, necessary for the implementation of the contingency plans.
Latest Available (revised):The latest available updated version of the legislation incorporating changes made by subsequent legislation and applied by our editorial team. Changes we have not yet applied to the text, can be found in the ‘Changes to Legislation’ area.
Original (As adopted by EU): The original version of the legislation as it stood when it was first adopted in the EU. No changes have been applied to the text.
Point in Time: This becomes available after navigating to view revised legislation as it stood at a certain point in time via Advanced Features > Show Timeline of Changes or via a point in time advanced search.
Geographical Extent: Indicates the geographical area that this provision applies to. For further information see ‘Frequently Asked Questions’.
Show Timeline of Changes: See how this legislation has or could change over time. Turning this feature on will show extra navigation options to go to these specific points in time. Return to the latest available version by using the controls above in the What Version box.
Access essential accompanying documents and information for this legislation item from this tab. Dependent on the legislation item being viewed this may include:
This timeline shows the different versions taken from EUR-Lex before exit day and during the implementation period as well as any subsequent versions created after the implementation period as a result of changes made by UK legislation.
The dates for the EU versions are taken from the document dates on EUR-Lex and may not always coincide with when the changes came into force for the document.
For any versions created after the implementation period as a result of changes made by UK legislation the date will coincide with the earliest date on which the change (e.g an insertion, a repeal or a substitution) that was applied came into force. For further information see our guide to revised legislation on Understanding Legislation.
Use this menu to access essential accompanying documents and information for this legislation item. Dependent on the legislation item being viewed this may include:
Click 'View More' or select 'More Resources' tab for additional information including: